BioRestorative Therapies, Inc. (BRTX) has 103 open-market insider trades by 12 insiders since 2012. The most active filer is Dale Broadrick, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Dale Broadrick | 10% Owner | — | 36 | $5.5M | 2024-10-28 |
| John M. Desmarais | Dir10% Owner | — | 2 | $1.2M | 2017-03-01 |
| Robert B. Catell | Dir | — | 3 | $214K | 2018-05-09 |
| Francisco Silva | VP | — | 14 | $179K | 2025-10-06 |
| Lance Alstodt | CEOPresCOB | — | 33 | $138K | 2025-10-06 |
| Charles S. Ryan | Dir | — | 2 | $75K | 2017-03-01 |
| Paul Jude Tonna | Dir | — | 3 | $54K | 2019-08-29 |
| Robert Eugene Kristal | CFO | — | 3 | $45K | 2022-06-15 |
| Joseph B. Swiader | Dir | — | 1 | $25K | 2015-03-31 |
| Mandy D. Clark | VP of Operations | — | 1 | $13K | 2012-10-15 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Dale Broadrick | 10% | Sell | $2K | 2024-10-28 |
| Francisco Silva | VP of Research and Development | Buy | $10K | 2024-04-08 |
| Dale Broadrick | 10% Owner | Buy | $412K | 2024-02-08 |
| Dale Broadrick | 10% Owner | Buy | $325K | 2024-02-07 |
| Dale Broadrick | 10% | Sell | $470 | 2023-12-01 |
| Dale Broadrick | 10% | Sell | $525 | 2023-11-27 |
Companies that share insiders with BRTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Lance Alstodt | CEO & President +2 | Buy | $4K | 2023-09-15 |
| Dale Broadrick | 10% | Buy | $32K | 2023-09-14 |
| Lance Alstodt | CEO & President +2 | Buy | $1K | 2023-09-13 |
| Lance Alstodt | CEO & President +2 | Buy | $6K | 2023-09-06 |
| Francisco Silva | VP of Research and Development & 10% | Buy | $11K | 2023-08-31 |
| Dale Broadrick | 10% | Buy | $5K | 2023-07-28 |
| Dale Broadrick | 10% | Buy | $3K | 2023-07-27 |
| Lance Alstodt | CEO & President +2 | Buy | $10K | 2023-07-25 |
| Francisco Silva | VP of Research and Development & 10% | Buy | $3K | 2023-03-31 |